> Novo Nordisk ($NVO) has launched an online news channel as part of its new website for hemophilia patients, RareBleedingDisorders.com. More
> Sanofi's ($SNY) multiple sclerosis pill, Aubagio, slowed brain atrophy in a Phase III trial. Release
> The U.S. Department of Health and Human Services (HHS) is considering ideas to control drug prices, including contracting with drugmakers to pay based on performance. More (sub. req.)
> Formycon and Bioeq have launched a Phase III trial of their biosimilar of Roche's ($RHHBY) Lucentis. Report
And Finally... A guerrilla advertising campaign in Australia is encouraging gay men to have unprotected sex to promote Gilead's ($GILD) Truvada, which reduces the risk of contracting HIV. More